Mark Hirschhorn, who serves as Chief Financial Officer at American Well Corp (NASDAQ:AMWL), completed a share disposition on July 1, 2026. The transaction involved the sale of 4,299 shares of the company's Class A Common Stock. Each share was sold at $9.33, resulting in a total transaction value of $40,109. This sale activity occurred while AMWL shares were trading close to their 52-week peak of $9.96, a level reached after the stock experienced an 86% increase over the previous six months.
The specific nature of this transaction was non-discretionary. Hirschhorn sold the shares to cover tax liabilities that arose from the vesting and settlement of restricted stock units on the same date. This mechanism is commonly referred to as a sell-to-cover transaction. It does not indicate a voluntary reduction in holdings by the executive. Following the completion of this sale, Hirschhorn's direct ownership of American Well Corp Class A Common Stock stands at 238,939 shares.
Financial performance data from Amwell provides additional context for the stock's recent movement. The company reported its first-quarter 2026 results, which showed total revenue of $54.9 million. This figure represents an 18% decrease compared to the same period in the previous year. Despite the revenue contraction, the company demonstrated a 43% improvement in its operating loss, indicating a trajectory toward operational efficiency. Market analysts at Truist Securities reiterated a Hold rating on Amwell stock, maintaining a price target of $7.50.
Corporate leadership changes also accompany these financial updates. Dr. Roy Schoenberg, co-founder of Amwell, has resigned from the board of directors. This departure follows his decision to assume leadership of Amazon's healthcare unit. The company clarified that his exit is not due to any disagreements with Amwell and acknowledged his significant contributions to the organization.
Product developments remain a focal point for the telehealth sector. Amwell's SilverCloud digital mental health platform reported positive results from a study funded by the National Institute of Mental Health. The study involved over 6,000 students across 26 U.S. colleges. Published in Nature Human Behaviour, the research aimed to support students at risk for anxiety, depression, or eating disorders. These developments highlight Amwell's ongoing strategic efforts within the telehealth sector.